PITUITARY-DEPENDENT CUSHING'S SYNDROME side effect
What is PITUITARY-DEPENDENT CUSHING'S SYNDROME ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
PITUITARY-DEPENDENT CUSHING'S SYNDROME and Recently Reported Side Effects
PITUITARY-DEPENDENT CUSHING'S SYNDROME and 15 most Active Side Effect polls
PITUITARY-DEPENDENT CUSHING'S SYNDROME and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Atmadisc Side Effects Report #5648698-4
Physician from GERMANY reported ATMADISC MITE problem on Feb 26, 2008. Male patient, child 7 years of age, was treated with ATMADISC MITE. After drug was administered, patient experienced the following problems/side effects: central obesity, pituitary-dependent cushing's syndrome, . ATMADISC MITE dosage: unknown. Patient recovered.
Genotropin Side Effects Report #5603220-3
GENOTROPIN problem was reported by a Consumer or non-health professional from GERMANY on Jan 15, 2008. Female patient, 44 years of age, weighting 149.9 lb, was diagnosed with hypopituitarism and was treated with GENOTROPIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, pituitary-dependent cushing's syndrome, . GENOTROPIN dosage: unknown. During the same period patient was treated with HYDROCORTISON, GABAPENTIN, CALCIUM. Patient was hospitalized. Patient recovered.
Atmadisc Side Effects Report #5522214-X
Physician from GERMANY reported ATMADISC MITE problem on Nov 15, 2007. Male patient, child 7 years of age, was treated with ATMADISC MITE. After drug was administered, patient experienced the following problems/side effects: central obesity, pituitary-dependent cushing's syndrome, . ATMADISC MITE dosage: unknown. Patient recovered.
Orlistat Side Effects Report #5714952-0
ORLISTAT problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 16, 2008. Female patient, weighting 273.4 lb, was diagnosed with obesity and was treated with ORLISTAT. After drug was administered, patient experienced the following problems/side effects: benign neoplasm, pituitary-dependent cushing's syndrome, . ORLISTAT dosage: unknown. Patient recovered.